Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-114787

General Counsel and Secretary sold 1,089 shares at $46.28 ($50,399)

  • General Counsel and Secretary acquired 2,113 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
KASINGER JAMES R. General Counsel and Secretary 2024-10-13 Option exercise +2,113 63,686 D
KASINGER JAMES R. General Counsel and Secretary 2024-10-14 Sale −1,089 $46.28 $50,399 62,597 D
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2024-10-13 Option exercise · Restricted Stock Units −2,113 4,227 D
Open-market sales · 1,089 sh · avg $46.28 · $50,399
Loading xslF345X05/ownership.xml…